Virpax Pharmaceuticals analyst ratings
Virpax Pharmaceuticals analyst ratings
While ratings are subjective and will change, the latest Virpax Pharmaceuticals (VRPX) rating was a initiated with a price target of $0.00 to $4.00. The current price Virpax Pharmaceuticals (VRPX) is trading at is $1.55, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/09/2022 | 158.06% | Maxim Group | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 9 月 6 日 | 158.06% | Maxim 集团 | → 4 美元 | 启动覆盖范围开启 | → 购买 |
Virpax Pharmaceuticals Questions & Answers
Virpax 制药问题与解答
The latest price target for Virpax Pharmaceuticals (NASDAQ: VRPX) was reported by Maxim Group on June 9, 2022. The analyst firm set a price target for $4.00 expecting VRPX to rise to within 12 months (a possible 158.06% upside). 1 analyst firms have reported ratings in the last year.
Maxim集团于2022年6月9日公布了Virpax Pharmicals（纳斯达克股票代码：VRPX）的最新目标股价。该分析公司将目标股价定为4.00美元，预计VRPX将在12个月内升至12个月内（可能上涨158.06％）。1家分析公司去年公布了评级。
The latest analyst rating for Virpax Pharmaceuticals (NASDAQ: VRPX) was provided by Maxim Group, and Virpax Pharmaceuticals initiated their buy rating.
Virpax Pharmicals（纳斯达克股票代码：VRPX）的最新分析师评级由Maxim集团提供，Virpax Pharmicals启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Virpax Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Virpax Pharmaceuticals was filed on June 9, 2022 so you should expect the next rating to be made available sometime around June 9, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Virpax Pharmicals的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Virpax Pharmicals的最新评级是在2022年6月9日公布的，因此您应该预计下一个评级将在2023年6月9日左右公布。
While ratings are subjective and will change, the latest Virpax Pharmaceuticals (VRPX) rating was a initiated with a price target of $0.00 to $4.00. The current price Virpax Pharmaceuticals (VRPX) is trading at is $1.55, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Virpax Pharmicals（VRPX）评级是启动的，目标股价为0.00美元至4.00美元。Virpax Pharmicals（VRPX）目前的交易价格为1.55美元，在分析师的预测区间内。
